医保药品准入:Mini-HTA与RHTA适用性比较  

Medical Insurance Drug Admission:A Comparison of Mini-HTA and RHTA

作　　者：钟运香 尹霖 唐海鹏 王爱红 张倩雯 姜松 ZHONG Yunxiang;YIN Lin;TANG Haipeng;WANG Aihong;ZHANG Qianwen;JIANG Song(Dongguan Binhai Bay Central Hospital,Dongguan,Guangdong,China 523900;Dongguan Public Hospital Operation Service Center,Dongguan,Guangdong,China 523000)

机构地区：[1]广东省东莞市滨海湾中心医院,广东东莞523900 [2]广东省东莞市公立医院运营服务中心,广东东莞523000

出　　处：《中国药业》2025年第8期21-25,共5页China Pharmaceuticals

基　　金：广东省东莞市社会发展科技项目[20221800901052]。

摘　　要：目的比较2种卫生技术评估(HTA)方法在《国家基本医疗保险、工伤保险和生育保险药品目录》(简称《医保药品目录》)准入中的适用性。方法通过中国知网、万方和维普数据库检索HTA相关中文文献,检索时限为2020年1月1日至2023年5月22日。系统梳理并分析微型卫生技术评估(Mini-HTA)和快速卫生技术评估(RHTA)的评价体系,对比二者的方法适用性。结果Mini-HTA的评价体系包括药品特性、有效性、安全性、经济性和其他属性5个一级评价指标,以及相应的6,1,4,7,5个二级评价指标,权重相对固定。RHTA的评价体系包括有效性、安全性、经济性3个一级评价指标,以及相应的132,4,10个二级评价指标,能更全面反映药品质量。结论Mini-HTA更适用于《医保药品目录》药品的准入前评估,RHTA更适用于《医保药品目录》中药品的再评价。Objective To compare the applicability of two health technology assessment(HTA)methods in the access of drugs to the National Essential Medical Insurance,Work-Related Injury Insurance and Medical Insurance Drug List(referred as the Medical Insurance Drug List).Methods Chinese literature related to HTA was retrieved from CNKI,Wanfang and VIP databases,and the retrieval time limit was from January 1,2020 to May 22,2023 respectively.The evaluation systems of mini health technology assessment(Mini-HTA)and rapid health technology assessment(RHTA)were systematically sorted out and analyzed,and the applicability of the two methods was compared.Results The evaluation system of Mini-HTA includes five first-level evaluation indicators:drug characteristics,effectiveness,safety,economy and other attributes,and the corresponding 6,1,4,7 and 5 second-level evaluation indicators,with relatively fixed weights.The evaluation system of RHTA includes three first-level evaluation indicators:effectiveness,safety and economy,and the corresponding 132,4 and 10 second-level evaluation indicators,which can more comprehensively reflect the quality of drugs.Conclusion Mini-HTA is more suitable for the pre-access assessment of drugs in the Medical Insurance Drug List,and RHTA is more suitable for the re-evaluation of drugs in the Medical Insurance Drug List.

关 键 词：医保药品目录 医保调整 卫生技术评估 Mini-HTA RHTA 

分 类 号：R95[医药卫生—药学]